Hamehn pharma

Hameln Pharma is a privately owned pharmaceutical company headquartered in Hameln, Germany, specializing in the development and marketing of parenteral generic medicines. The company focuses on high-quality injectable products used primarily in hospital settings, with core expertise in anesthesiology, intensive care, and emergency medicine. With a history dating back to 1950, Hameln Pharma has established a significant international presence, distributing its portfolio to over 60 countries worldwide. Following the sale of its contract manufacturing business to Siegfried Holding in 2014, the company has pivoted to focus on its own product portfolio and global sales operations. Its offerings include essential medicines such as anesthetics, analgesics, and anti-infectives, recognized for their commitment to supply reliability and high regulatory standards.